Stocks-PHM.MC-Pharma Mar SA

PHM.MC Pharma Mar SA

0 0 (0%)
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Pharma Mar SA's revenues decreased by 14.57% and amounted to 196.34M. Net income decreased by 46.85% to 49.36M. Net assets increased by 25.31% to 222.96M and EPS decreased from N/A to N/A.
PHM.MC's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
92.24%
Net Profit Margin
26.43%
Operating Margin
0.28%
Return On Investment
36.41%